# Manufacture of Blood Components Using a Pathogen Reduction Device in Blood Establishments: Questions and Answers:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/manufacture-of-blood-components-using-a-pathogen-reduction-device-in-blood-establishments-questions-and-answers-guidance-for-industry/4bb1276b-ec33-409e-82ac-d359a4c4d5af

> FDA guidance document: Manufacture of Blood Components Using a Pathogen Reduction Device in Blood Establishments: Questions and Answers:  Guidance for Industry. Issue date: November 03, 2021. Get complete insights and analysis.

---

## Details

- Title: Manufacture of Blood Components Using a Pathogen Reduction Device in Blood Establishments: Questions and Answers:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2021-11-03
- Last Changed: 2021-11-08
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-6784">FDA-2017-D-6784</a>

## Related Documents

- [Human Gene Therapy for Rare Diseases:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-rare-diseases-guidance-for-industry/1cebc8e2-7d3b-4c5f-a4c4-78d1fc112099)
- [Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/studying-multiple-versions-of-a-cellular-or-gene-therapy-product-in-an-early-phase-clinical-trial-guidance-for-industry/8b768a82-5ebf-4899-ad60-25692f1674d9)
- [Human Gene Therapy for Hemophilia:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-hemophilia-guidance-for-industry/bceafce9-c9f0-4137-9ca5-071464212a06)